Ascentage Pharma Group International (NASDAQ:AAPG) Shares Gap Up – Here’s Why

Ascentage Pharma Group International (NASDAQ:AAPG) shares gapped up before the market opened on Thursday . The stock had previously closed at $29.75, but opened at $31.30. Ascentage Pharma Group International shares last traded at $31.62, with a volume of 6,835 shares.

Analysts Set New Price Targets

Separately, JPMorgan Chase & Co. started coverage on Ascentage Pharma Group International in a report on Thursday, March 27th. They set an “overweight” rating on the stock.

Ascentage Pharma Group International Price Performance

The firm has a fifty day moving average of $24.27.

Institutional Trading of Ascentage Pharma Group International

An institutional investor recently bought a new position in Ascentage Pharma Group International stock. Monashee Investment Management LLC purchased a new stake in shares of Ascentage Pharma Group International (NASDAQ:AAPG) during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 159,942 shares of the company’s stock, valued at approximately $3,511,000. Monashee Investment Management LLC owned 0.18% of Ascentage Pharma Group International as of its most recent filing with the SEC.

Ascentage Pharma Group International Company Profile

Ascentage Pharma Group International Co, Ltd. is a clinical-stage biotechnology company. It engages in the development of novel therapies for cancers, hepatitis B virus, or HBV, and age-related diseases. The company was founded by Da Jun Yang, Wang Shao Meng and Ming Guo in May 2009 and is headquartered in Suzhou, China.